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The Op-IAP protein from the baculovirus Orgyia pseudotsugata M nucleopolyhedrovirus (OpMNPV) is highly effective at inhibiting
apoptosis triggered by a variety of different stimuli in lepidopteran cells as well as in several different mammalian cell types, suggesting that
it functions at a highly conserved step in the apoptotic pathway. However, the mechanism by which Op-IAP inhibits apoptosis is unclear.
Since some IAP proteins can bind and inhibit caspases, we tested whether Op-IAP could inhibit the activity of caspases from Drosophila
melanogaster. We found that recombinant Op-IAP protein was not able to bind or directly inhibit the activity of the Drosophila caspases
DRONC, DrICE, or DCP-1 in vitro. In addition, expression of Op-IAP was unable to inhibit apoptosis triggered by either actinomycin D or
UV light in D. melanogaster S2 cells. Surprisingly, Op-IAP expression in S2 cells enhanced apoptosis caused by baculovirus infection, but
did not cause increased sensitivity to either actinomycin D or UV damage-induced apoptosis. The observation that Op-IAP cannot inhibit
these insect caspases suggests that it functions by a mechanism that does not involve direct caspase inhibition.
D 2005 Elsevier Inc. All rights reserved.
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Apoptosis is a genetically controlled program of cell
suicide. This form of programmed cell death is important for
proper development during embryogenesis, tissue homeo-
stasis, immune development, and function, and serves as a
line of defense against viral infection (Horvitz, 1999;
Jacobson et al., 1997; O’Brien, 1998; Rathmell and
Thompson, 2002). A fine balance between cell death and
life exists, and when components of the apoptotic program
malfunction disease states can occur. An important family of
proteins that regulate the cellular life–death balance is the
inhibitor of apoptosis (IAP) family (Salvesen and Duckett,0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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1301 Catherine, RM 5326, Ann Arbor, MI 48109-0602, USA.2002). IAP proteins were first identified in baculoviruses
and are now known to exist in a wide range of eukaryotes.
They are characterized by the presence of an ~70 amino acid
conserved zinc binding motif termed the baculovirus IAP
repeat (BIR), which is involved in protein–protein inter-
actions. Many IAPs also function as E3 ubiquitin ligases
transferring ubiquitin to target proteins by means of a
carboxy-terminal RING-finger (Jesenberger and Jentsch,
2002; Orlowski, 1999; Tyers and Willems, 1999; Yang et al.,
2000).
Caspases, cysteine proteases that cleave their substrates
following aspartic acid residues (Salvesen, 2002; Shi,
2002b), are present in metazoan cells in zymogen form
consisting of a large and small subunit preceded by a
prodomain. Caspases are activated in a hierarchical pattern
with the upstream initiator or apical caspase processing
itself after binding to adapter molecules. Once an apical
caspase is activated, it then cleaves and activates down-
stream effector caspases, which are responsible for the005) 61–71
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components. The cellular IAPs are thought to serve as a type
of rheostat, preventing caspase activation under normal
conditions but allowing it to proceed when an appropriate
signal is received (Miller, 1999). Some IAPs have been
shown to directly bind to caspases through interactions
within or immediately surrounding the BIR domains, and
also to ubiquitinate caspases, targeting them for proteasomal
degradation (Huang et al., 2000a; Suzuki et al., 2001;
Wilson et al., 2002).
The apoptotic threshold is overcome in mammalian
cells, in part, by the mitochondrial release of the pro-
apoptotic IAP antagonist, Smac (Du et al., 2000; Liu et al.,
2000; Srinivasula et al., 2000; Verhagen et al., 2000; Wu et
al., 2000). Smac is released from the mitochondria along
with other apoptotic factors, i.e., cytochrome c and Omi/
HrtA2, which contribute to caspase activation. Cytochrome
c binds to the adaptor molecule Apaf-1 and causes a
conformational change that allows recruitment and activa-
tion of the apical caspase-9. Smac antagonizes IAPs by
binding to them, thereby causing dissociation of the
activated bound caspase from the IAP and apoptosis
ensues.
On the other hand, apoptosis appears to be regulated
somewhat differently in Drosophila, where cytochrome c
release from mitochondria does not occur and is not
necessary for caspase activation (Dorstyn et al., 2002,
2004; Varkey et al., 1999; Zimmermann et al., 2002).
Instead, the apical caspase DRONC is constitutively active
in Drosophila cells, and DIAP1 is required for cell viability
because of its ability to promote DRONC ubiquitination and
degradation (Muro et al., 2002; Rodriguez et al., 2002;
Wilson et al., 2002). The Drosophila pro-apoptotic proteins
Reaper, Hid, and Grim function similarly to Smac in that
they are IAP antagonists and can therefore relieve the
inhibitory activity of DIAP1 on DRONC (Goyal et al.,
2000; Wang et al., 1999; Yoo et al., 2002). The available
evidence also indicates that the lepidopteran apoptotic
program is similar to that of Drosophila. Upon silencing
of Sf-IAP in the lepidopteran cell line SF-21, the cells
underwent spontaneous apoptosis suggesting that Sf-IAP is
also required to inhibit a constitutively activated caspase,
similar to DIAP1 in Drosophila (Muro et al., 2002).
Therefore, superficially it may appear that IAPs are mostly
similar in how they function, by directly binding and
inhibiting active caspases. However, the IAPs have been
implicated in other cellular processes, extending their
function beyond mere caspase inhibition in the regulation
of the apoptotic program (Birkey Reffey et al., 2001; Fraser
et al., 1999; Li et al., 1998; Uren et al., 1999).
The Op-iap3 gene is found in the baculovirus Orgyia
pseudotsugata M nucleopolyhedrovirus (OpMNPV) and
was one of the first iap genes identified (Birnbaum et al.,
1994). Using RNA-mediated interference, it was demon-
strated that the Op-IAP protein is required to prevent
apoptosis during OpMNPV infection of LD652Y cells,derived from the lepidopteran insect Lymantria dispar
(Means et al., 2003). Exogenous expression of Op-IAP
has also been reported to inhibit apoptosis in both
lepidopteran and mammalian cells. More specifically, in
addition to LD652Y cells, Op-IAP has been shown to
potently protect cells derived from Spodoptera frugiperda
(SF-21 cells), HeLa cells, 293 (human embryonic kidney)
cells, Chinese hamster ovary cells, and transgenic murine
thymocytes from undergoing apoptosis induced by multiple
stimuli (Clem and Miller, 1994; Hawkins et al., 1996, 1998;
Manji et al., 1997; Robles et al., 2002; Vucic et al., 1997,
1998a). Although Op-IAP has been studied for more than 10
years and can protect a number of cell types from numerous
death signals, its mechanism of anti-apoptotic function is
not very well understood.
Op-IAP binds to the Drosophila pro-apoptotic proteins
Hid, Reaper, and Grim, and inhibits apoptosis caused by
overexpression of these proteins in SF-21 cells (Vucic et al.,
1997, 1998a; Wright and Clem, 2002). These pro-death
proteins all harbor what has been termed an IAP binding
motif consisting of four amino acids at their amino terminus
immediately following the initiating methionine (Shi,
2002a). The interaction between Op-IAP and the IAP
binding motif of Hid occurs only after the methionine is
removed by a metalloprotease, presumably a methionine
aminopeptidase (Wright and Clem, 2002). Furthermore, the
interaction between Op-IAP and the amino terminus of Hid
is conserved in mammals, i.e., the interaction between the
mammalian X-linked IAP (XIAP) and the mammalian IAP
antagonist Smac. However, there are Op-IAP mutants that
bind Hid normally but are unable to block Hid-induced
apoptosis (Vucic et al., 1998b; Wright and Clem, 2002),
leading to the conclusion that Op-IAP must possess other
mechanisms of apoptosis inhibition.
The conventional wisdom of IAP function, as stated
above, is that IAPs protect cells by inhibiting caspase
activity through direct binding in the caspase active site.
However, Op-IAP cannot inhibit the activity of the
mammalian apical caspases-2, -8, or -9, nor the effector
caspases-3, -6, or -7 in vitro (Huang et al., 2000b; Wilkinson
et al., 2004), even though it can inhibit apoptosis in
mammalian cells (Hawkins et al., 1996, 1998; Huang et
al., 2000b). Expression of Op-IAP can inhibit, either
directly or indirectly, a caspase-like activity in SF-21 cells
which has been attributed to an unidentified apical caspase
termed Sf-caspase-X, but available evidence indicates that
Op-IAP functions upstream of Sf-caspase-X (LaCount et al.,
2000; Zoog et al., 2002). Op-IAP has also been shown to
possess E3 ubiquitin protein ligase activity and can promote
ubiquitination of itself and of Hid (Green et al., 2004).
To further address the question of whether Op-IAP can
directly inhibit caspases, we chose to examine Drosophila
caspases since lepidopteran apical initiator caspases have not
been identified to date, and Op-IAP is unable to inhibit the
activity of the lepidopteran effector caspase Sf-caspase-1
(Manji et al., 1997; Seshagiri and Miller, 1997). Op-IAP
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phila caspases DRONC, DrICE, or DCP-1 in vitro. However,
in the course of characterizing the ability of Op-IAP to
directly inhibit Drosophila caspase activity, we found that
Op-IAP could not inhibit apoptosis in Drosophila S2 cells.
Furthermore, Op-IAP expression sensitized S2 cells to apop-
tosis induced by baculovirus infection, but not to apoptosis
stimulated by actinomycin D or UV-induced damage.Results
Op-IAP cannot inhibit Drosophila caspase activity in vitro
To determine whether Op-IAP can directly inhibit
Drosophila caspases, we expressed a GST-Op-IAP fusion
protein, which has an N-terminal GST tag, in bacteria and
purified it using glutathione-conjugated beads. As controls,Fig. 1. Op-IAP does not inhibit Drosophila caspase activity in vitro. Recombinant D
either alone or with increasing concentrations of the recombinant proteins GS
Fluorogenic caspase substrates were then added (Ac-IETD-AFC to the DRONC rea
activity was assessed by measuring relative fluorescence units (RFU) after 1 h of
alone. The results shown are the means F standard error of three independent aswe also expressed and purified GST and GST-DIAP1 in a
similar fashion. We also expressed the Drosophila caspases
DRONC-His6, DrICE-His6, and DCP-1-His6 in bacteria and
purified them using cobalt resin. DRONC is an apical
caspase responsible for activating downstream effector
caspases, while DrICE and DCP-1 are effector caspases
whose protease activity is thought to lead directly to the
death of the cell. To measure caspase activity, we used the
fluorogenic caspase substrates Ac-IETD-AFC (an apical
caspase substrate recognized by DRONC) or Ac-DEVD-
AFC (an effector caspase substrate recognized by DrICE
and DCP-1).
When increasing concentrations of GST or GST-Op-IAP
were preincubated with DRONC-His6, DrICE-His6, or
DCP-1-His6, caspase activity was not inhibited (Fig. 1),
indicating that Op-IAP was unable to directly inhibit the
activity of any of these caspases in vitro. GST-DIAP1
inhibited DCP-1-His6 activity in vitro, but failed to inhibitRONC-His6, DrICE-His6, or DCP-1-His6 protein was incubated for 30 min
T, GST-DIAP1, or GST-Op-IAP, or the caspase inhibitor Z-VAD-FMK.
ctions and Ac-DEVD-AFC to the DrICE and DCP-1 reactions) and caspase
incubation. In reactions labeled bbufferQ, substrate was incubated in buffer
says.
Fig. 2. Op-IAP does not bind Drosophila caspases in vitro. Recombinant
GST-DIAP1 (A) or GST-Op-IAP (B) fusion protein was incubated with
DrICE-His6, DCP-1-His6, DRONC-His6, or catalytically inactive DRONC-
His6(C318S), and the reactions were then subjected to pull-down assay with
anti-His antibody or with Hid peptide. Interacting proteins were analyzed
by Western blot using anti-DIAP1 (A) or anti-Op-IAP (B) antibodies. The
lanes labeled bInputQ contain 10% of the protein used in each pull-down
reaction.
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previous reports (Chai et al., 2003; Hawkins et al., 1999,
2000). As expected, all three caspases were inhibited by the
pan-caspase inhibitor Z-VAD-FMK.
Op-IAP cannot bind caspases in vitro
In order to understand why Op-IAP could not inhibit any
of the Drosophila caspases tested in vitro, we hypothesized
that Op-IAP could not directly bind to the caspases
themselves. To address our hypothesis, we performed co-
immunoprecipitation experiments where equivalent concen-
trations of GST-DIAP1 or GST-Op-IAP were mixed with
similar concentrations of DRONC-His6, a catalytically inac-
tive DRONC mutant (DRONC-His6(C318S)), DCP-1-His6,
or DrICE-His6, and incubated for 1 h to allow association.
Following incubation, samples were immunoprecipitated
with anti-His antibody and precipitated proteins were ana-
lyzed by Western blot analysis using anti-DIAP1 or anti-Op-
IAP antibodies. As shown in Fig. 2, DRONC-His6,
DRONC-His6(C318S), DCP-1-His6, and DrICE-His6 bound
to GST-DIAP1 but none of the caspases tested could bind to
GST-Op-IAP. To insure that the GST-Op-IAP fusion protein
was properly folded, we performed circular dichroism
analysis of purified GST-Op-IAP, which revealed the
presence of alpha helices and beta sheets (data not shown).
In addition, GST-Op-IAP was able to bind a peptide
containing the amino terminus of Hid (Fig. 2B). These
results, in addition to the fact that GST-Op-IAP purified
under similar conditions has in vitro ubiquitin ligase activity
(Green et al., 2004), strongly support the presence of a
correctly folded protein in our assays.
Op-IAP cannot protect Drosophila S2 cells against UV- or
actinomycin D-induced apoptosis
In the course of examining the ability of Op-IAP to
inhibit Drosophila caspases, we asked whether or not
expression of Op-IAP could inhibit apoptosis in Drosophila
S2 cells. To test this, we transiently co-transfected Droso-
phila S2 cells with plasmids encoding HA-tagged Op-IAP
(HA-Op-IAP) and enhanced green fluorescent protein
(eGFP) and then UV-irradiated the cells 20 h later. Trans-
fected (green) cells were scored at 2 h and 24 h after UV
treatment, and cell viability was calculated by dividing by
the number of transfected cells left at 24 h by the number
present at 2 h. S2 cells were efficiently protected by
overexpression of HA-DIAP1, but HA-Op-IAP was unable
to protect S2 cells from UV-induced apoptosis even though
it was expressed at levels equivalent to DIAP1 (Fig. 3A and
data not shown). Although unable to protect S2 cells, HA-
Op-IAP protected SF-21 cells against UV-induced apoptosis
(Fig. 3A) as has been demonstrated previously (Manji et al.,
1997).
Because the presence of an epitope tag can interfere with
the ability of Op-IAP to protect mammalian cells (ColinDuckett, personal communication), we tested whether Op-
IAP could protect S2 cells when the HA-tag was removed.
As shown in Fig. 3B, the presence or absence of the HA-tag
on Op-IAP did not affect the ability of Op-IAP to protect S2
cells, although removal of the HA-tag did cause a slight
increase in the activity of Op-IAP in SF-21 cells, as well as
that of DIAP1 in S2 cells. Results similar to those shown in
Figs. 3A and B were obtained when actinomycin D was
used to stimulate apoptosis (data not shown).
Op-IAP sensitizes Drosophila S2 cells to
baculovirus-induced apoptosis
As a different method of expressing Op-IAP in S2 cells,
we constructed a recombinant of the baculovirus Auto-
Fig. 3. Op-IAP does not inhibit apoptosis in Drosophila S2 cells. (A) A
plasmid expressing eGFP was transfected into S2 or SF-21 cells either
alone or together with the indicated plasmids expressing HA-DIAP1 or HA-
Op-IAP from the heat shock (HS) promoter. The cells were UV irradiated
and the relative viability of the cells 24 h later was determined as described
in Materials and methods. HA-Op-IAP and HA-DIAP1 were expressed in
S2 cells at roughly equal levels as judged by Western blotting with anti-HA
(data not shown). (B) Removing the HA epitope tag had no effect on the
ability of Op-IAP to block UV-induced apoptosis in S2 cells but had a slight
positive effect in SF-21 cells (compare A and B).
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caspase inhibitor p35 but expressed HA-tagged Op-IAP
from a Drosophila hsp70 promoter (vHAOp-IAP).
AcMNPV is able to enter Drosophila cells and although
some viral genes are expressed, no viral replication occurs
(Carbonell et al., 1985; Lee et al., 2000; Morris and Miller,
1992, 1993). However, genes under the control of the
Drosophila hsp70 promoter are highly expressed. Mutants
of AcMNPV that lack the p35 gene induce apoptosis in
several different lepidopteran cell lines, as well as in
Drosophila DL-1 cells (Clem, 2001; Zoog et al., 2002).
We thus used this recombinant virus as a vector for
expression of HA-Op-IAP in S2 cells.
Infection of S2 cells with a virus containing the p35 gene
(vHSGFP) did not induce apoptosis, while infection of cellswith a virus lacking the p35 gene (vHSGFP/P35del) caused
a reduction in viability of around 50% at 30 h post-infection
(Fig. 4A). However, it was immediately clear from
observing the cells that apoptosis was more prevalent in
vHAOp-IAP-infected cells. Measurement of the viability of
S2 cells infected with vHAOp-IAP indicated that the
number of viable cells remaining at 30 h post-infection
was only around 10% (Fig. 4A). Cell death did not start to
occur until around 24 h post-infection, but Op-IAP was
expressed at high levels in cells infected with vHAOp-IAP
prior to this time (Fig. 4B). Dying cells infected with either
vHSGFP/P35del or vHAOp-IAP exhibited typical morpho-
logical characteristics of apoptosis, including cell blebbing
and nuclear fragmentation (data not shown). Both apical
and effector caspase activities (as measured by cleavage of
IETD-AFC and DEVD-AFC, respectively) were also
increased in cells infected with vHAOp-IAP when com-
pared to vHSGFP/P35del and vHSGFP, with activities of
both types of caspases being highest in vHAOp-IAP-
infected cells (Fig. 4C). To rule out the possibility that
the differences in the amount of apoptosis observed were
due to differences in the abilities of the viruses to infect the
cells, the infection rates for all three viruses were
determined. Immunofluorescence using an antibody against
the viral IE1 protein at 12 h post-infection indicated that
between 98% and 99% of cells were infected by each virus
(Fig. 4D, panels a–f). Staining was not observed in mock-
infected cells (Fig. 4D, panels g and h) or when infected
cells were stained with secondary antibody alone (data not
shown).
Finally, we explored the possibility that Op-IAP may
sensitize these cells to other apoptotic stimuli in addition to
viral infection. S2 cells were transiently transfected with a
control plasmid or with Op-IAP- or DIAP1-expressing
plasmids and then treated with UV radiation or actinomycin
D. Since the levels of UV and actinomycin D that we
normally use result in almost complete cell death (Fig. 3),
we used lower doses of each stimulus that only induced
apoptosis in 40–60% of untransfected cells. As shown in
Fig. 5, Op-IAP expression did not cause increased
apoptosis in response to either stimulus, indicating that
the sensitizing effect of Op-IAP on apoptosis was stimulus-
dependent.Discussion
In this study, we found that Op-IAP was unable to
inhibit the activity of the Drosophila caspases DRONC,
DrICE, or DCP-1 in vitro, nor could it bind to any of these
caspases. Op-IAP also failed to inhibit apoptosis in
Drosophila S2 cells induced by UV irradiation, actino-
mycin D, or infection with p35 mutant AcMNPV. Surpris-
ingly, not only was Op-IAP unable to inhibit apoptosis in
S2 cells induced by these stimuli, it actually sensitized S2
cells to virus-induced apoptosis, but not to apoptosis
Fig. 4. Op-IAP sensitizes Drosophila S2 cells to virus-induced apoptosis. (A) S2 cells were infected with the indicated viruses, and at 30 h post-infection the
percent viability relative to the mock-infected control was determined. (B) S2 cells were infected with vHAOp-IAP and at 12, 18, and 24 h post-infection cells
were harvested and analyzed by Western blot using an anti-HA antibody. (C) S2 cells were infected with the indicated viruses and at 30 h post-infection the
cells were harvested and caspase activity was quantified using the caspase substrates Ac-IETD-AFC (left panel) or Ac-DEVD-AFC (right panel). (D) S2 cells
were infected with vHSGFP/P35del (a–b), vHAOp-IAP (c–d), vHSGFP (e–f), or mock infected (g–h), and at 12 h post-infection the cells were stained with
antibody against the viral IE1 protein and fluorescent secondary antibody. In panels a, c, e, and g, the cells were viewed under normal light, while in panels b, d,
f, and h, the cells were viewed under fluorescence.
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seem unusual, it is not unheard of for proteins that regulate
apoptosis to have opposite activities under different
circumstances. For example, the mammalian anti-apoptotic
proteins Bcl-2 and Bad are normally anti-apoptotic and pro-
apoptotic, respectively. However, under certain circum-
stances, both proteins can have the opposite function
(Cheng et al., 1997; Fannjiang et al., 2003; Seo et al.,
2004). In addition, both nuclear factor-kappaB (NF-nB) andc-Jun N-terminal kinase (JNK) signaling can be anti-
apoptotic or pro-apoptotic, depending on the context of
the cells and the organism (Liu and Lin, 2005; Shishodia
and Aggarwal, 2004). Although Op-IAP is not normally
found in S2 cells, these observations may prove useful
because they provide clues pertaining to the biochemical
function of Op-IAP.
DIAP1 is known to inhibit apical and effector caspases
by different mechanisms. Using conditions similar to what
Fig. 5. Op-IAP does not sensitize S2 cells to other apoptotic stimuli. S2
cells were transfected with vector expressing eGFP alone or together with
vectors expressing DIAP1 or Op-IAP from the viral IE1 promoter and then
treated with low doses of UV or actinomycin D that only induced 40–60%
apoptosis in control cells. The relative viability of the transfected cells was
determined 24 h later as described in Materials and methods. HA-DIAP1
and HA-Op-IAP were expressed in roughly equivalent amounts (data not
shown).
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directly inhibited the enzymatic activity of DCP-1 in vitro,
but did not inhibit the activity of DrICE. It was later
shown that inhibition of DrICE by DIAP1 is improved if
the first 20 amino acids of DIAP1, which form an auto-
inhibitory domain, are removed (Yan et al., 2004). On the
other hand, DIAP1 does not directly inhibit DRONC
activity and instead assists in the ubiquitination and
degradation of DRONC (Chai et al., 2003; Wilson et al.,
2002). Op-IAP also has E3 ubiquitin ligase activity and
can ubiquitinate the Hid protein (Green et al., 2004), and
the RING motif of Op-IAP is important for its anti-
apoptotic function (Clem and Miller, 1994; Vucic et al.,
1998b; Wright and Clem, 2002). However, because Op-
IAP cannot interact with DRONC or any of the other
caspases tested, it is unclear at this time whether
ubiquitination of caspases has any bearing on the anti-
apoptotic activity of Op-IAP.
Although Op-IAP could not inhibit any of the Droso-
phila caspases tested, we still cannot formally rule out the
possibility that a lepidopteran caspase exists that Op-IAP
can physically bind to and inhibit or ubiquitinate. For
example, Op-IAP may directly inhibit the as yet unidentified
apical Sf-caspase-X. However, we consider this unlikely for
several reasons. First, compelling data exist suggesting that
Op-IAP inhibits the apoptotic program in SF-21 cells at a
point in the pathway prior to the activation of Sf-caspase-X
(Zoog et al., 2002). Second, in Drosophila, DRONC is the
only apical caspase activated following a variety of
apoptotic stimuli, and Op-IAP does not bind to or inhibit
DRONC. Third, Op-IAP inhibits apoptosis in mammaliancells, but its ability to do so correlates with its ability to bind
to Smac, and it does not directly inhibit any of several
mammalian caspases that have been tested (Wilkinson et al.,
2004). Thus the possibility that Op-IAP functions by
inhibiting caspases in lepidopteran cells seems highly
unlikely, given that it does not directly inhibit caspases
from another type of insect and that it functions in
mammalian cells by a mechanism that does not involve
direct caspase inhibition.
We also found that Op-IAP failed to inhibit apoptosis in
S2 cells induced by baculovirus infection. This result is
similar to a report by Zoog et al. (2002), in which Op-IAP
failed to inhibit apoptosis induced by infection of a
different Drosophila cell line, DL-1 cells, with a baculo-
virus lacking p35. In addition to this, however, we found
that Op-IAP actually sensitized S2 cells to baculovirus-
induced apoptosis. The fact that Op-IAP did not sensitize
S2 cells to UV or actinomycin D-induced apoptosis
suggests that virus infection may stimulate a different
apoptotic pathway than these other stimuli. Although the
mechanism by which Op-IAP sensitizes S2 cells to
baculovirus-induced apoptosis is unknown, it is possible
that the Op-IAP protein is influencing signal transduction
pathways, such as the NF-nB signaling pathway, which can
be either pro-apoptotic or anti-apoptotic, depending on the
cell type and the organism. Op-IAP expression has been
shown to induce NF-nB signaling in mammalian cells
(Robles et al., 2002, 2003), and NF-nB signaling can be
pro-apoptotic in Drosophila (Georgel et al., 2001). Thus
further experiments examining how Op-IAP expression
influences these types of signaling pathways may prove
illuminating.
Op-IAP appears to inhibit apoptosis in mammalian cells
through titration of Smac and cannot directly inhibit any of
several mammalian caspases that have been tested (Wilkin-
son et al., 2004). This result, along with the results here
showing that Op-IAP is unable to inhibit apoptosis in
Drosophila and is unable to directly bind to and inhibit
Drosophila caspases, suggests that Op-IAP blocks apoptosis
in lepidopteran cells by a mechanism that does not require
direct caspase inhibition. However, conclusive evidence
awaits the identification of apical caspases in lepidopteran
insects.Materials and methods
Cell lines and viruses
S. frugiperda IPLB-SF-21 (SF-21) and Trichoplusia ni
(TN-368) cells were maintained in TC-100 medium
(Invitrogen) supplemented with tryptose broth and 10%
fetal bovine serum (Invitrogen) (complete TC-100). Droso-
phila melanogaster S2 cells were maintained in Schneider’s
Drosophila media (Invitrogen) supplemented with 10%
fetal bovine serum. Cells were incubated at 27 8C and
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Construction of the vHSGFP strain of AcMNPV has been
described previously (Clarke and Clem, 2002), as has the
construction of the AcMNPV p35 deletion virus vHSGFP/
P35del (Clarke and Clem, 2003). The recombinant virus
vHAOP-IAP was constructed by homologous recombina-
tion of AcMNPV sequences in the pHSEpiOp-IAP shuttle
vector (Vucic et al., 1997) with sequences flanking the
polyhedrin region of vHSGFP/P35del, which replaced the
eGFP coding sequence with that of Op-IAP under hsp70
promoter control.
Plasmid construction
Plasmids expressing HA-OpIAP, HA-DIAP1, and eGFP
under the control of the Drosophila hsp70 heat shock
promoter have previously been described (Clem and Miller,
1994; Vucic et al., 1997, 1998a; Wright and Clem, 2002).
For expression driven by the baculovirus IE1 promoter,
HA-Op-IAP and HA-DIAP1 were amplified by PCR and
cloned downstream of the IE1 promoter in the pIE1hr/PA
vector (a gift from Paul Freisen, University of Wisconsin-
Madison). For glutathione-S-transferase (GST)-tagged Op-
IAP, the Op-IAP coding sequence was PCR-amplified and
introduced into the GST expression vector pGEX3X
(Amersham Pharmacia). A similar plasmid expressing
GST-DIAP1 was provided by Bruce Hay (California
Institute of Technology) (Hawkins et al., 1999). As in
Hawkins et al. (1999), the coding sequences for DCP-1
(initiating at codon 31) and DrICE (initiating at codon 81)
were PCR-amplified and cloned into the pET23a(+)
(Novagen) vector. These plasmids thus expressed versions
of DCP-1 and DrICE lacking the prodomain and containing
a C-terminal His6 tag. pET23a-DRONC and pET23a-
DRONC (C318S) were provided by Bruce Hay (Hawkins
et al., 2000).
Expression and purification of recombinant IAPs and
caspases
GST-DIAP1, GST-Op-IAP, DRONC-His6, DRONC
(C318S)-His6, DrICE-His6, and DCP-1-His6 were purified
from BL21(DE3)pLysS (Novagen) E. coli by inoculating 1
l of LB medium with 50 ml of an overnight culture that had
been grown with shaking at 37 8C. The inoculated 1-l
culture was then grown at room temperature until the
OD600 reached 0.4, followed by induction of protein
expression by addition of IPTG to a final concentration
of 0.1 mM and incubation for an additional 1 h. The cells
were lysed by sonication and the protein was purified by
incubating the bacterial lysate with either glutathione-
conjugated beads for GST-DIAP1 and GST-Op-IAP, or
with Talon resin (BD Clontech) for the His6-tagged
caspases for 1 h with rocking at 4 8C. The buffers and
storage protocols used were as described (Hawkins et al.,
1999).Caspase activity assay
Increasing concentrations of GST, GST-DIAP1, GST-
Op-IAP, or Z-VAD-FMK were incubated with 0.5 AM cas-
pase (DRONC-His6, DrICE-His6, or DCP-1-His6) in
caspase activity buffer (50 mM Hepes, pH 7.5, 100 mM
NaCl, 1 mM EDTA, 0.1% CHAPS, 10% sucrose, 5 mM
DTT) for 30 min at 30 8C. All caspase inhibitors and
substrates were purchased from Enzyme Systems Products.
Following incubation, the caspase-8 substrate, Ac-IETD-
AFC (100 AM), was added to samples containing DRONC
and the caspase-3 substrate, Ac-DEVD-AFC (100 AM),
was added to samples containing DrICE or DCP-1. After 1-
h incubation at 30 8C, caspase activity was determined as
an increase in fluorescence detection caused by the enzy-
matic cleavage of the substrate and the release of AFC
(7-amino-(trifluoromethyl)coumarin). When necessary,
reactions were diluted to maintain enzyme activity in the
linear range.
Caspase-IAP co-immunoprecipitations
Equal concentrations of protein were used (as determined
by comparison with BSA standards on a coomassie stained
gel). Recombinant GST-DIAP1 or GST-Op-IAP was added
to DrICE-His6, DCP-1-His6, DRONC-His6, or catalytically
inactive DRONC-His6(C318S) in 45 Al Buffer A (25 mM
Tris–HCL, pH 8, 50 mM NaCl, 10 mM DTT) and incubated
for 1 h at 30 8C. The reactions were then added to protein G
beads that had been preincubated with anti-His antibody
(His-Probe H-3, Santa Cruz Biotechnology) and rocked
overnight at 4 8C. As a positive control, GST-Op-IAP was
incubated with a biotinylated peptide consisting of amino
acids 2–11 of the Hid protein that had been previously
incubated with streptavidin beads as described (Wright and
Clem, 2002). The beads were washed 3 times with Buffer A
and bound protein was removed from the protein G beads or
streptavidin beads by boiling the samples in Laemmli buffer
for 5 min. The eluted protein was separated on a 15% SDS–
PAGE gel, transferred to PVDF, and DIAP1 or Op-IAP
protein was detected by Western blot using anti-DIAP1
monoclonal antibody (Muro et al., 2002) or anti-Op-IAP
polyclonal antiserum (Means et al., 2003) at a 1:100 dilution
followed by anti-mouse-HRP IgG antibody at 1:3000 for
DIAP1 and anti-rabbit-HRP IgG antibody at 1:10,000 for
Op-IAP.
Transfections and protection assays
3  106 S2 cells or 0.5  106 SF-21 cells were
transfected with 3 Ag of the indicated plasmid DNA along
with 3 Ag of a plasmid expressing eGFP. Cellfectin reagent
(Invitrogen) was used for S2 cells and a liposome reagent
(LaCount et al., 2000) was used for SF-21 cells. At 20 h
post-transfection, the cells were treated with UV by placing
the plates on a transilluminator for 10 min at an intensity of
C.W. Wright et al. / Virology 335 (2005) 61–71 698000 AW/cm2 (312 nm wavelength) or actinomycin D was
added at 500 ng/ml to induce apoptosis. 60% UV intensity
and 25 ng/ml actinomycin D were used as suboptimal
apoptotic treatments in the sensitization experiments. At 24 h
post-treatment, viable eGFP-positive cells were scored and a
percent relative viability was generated by dividing by the
number of viable eGFP positive cells at 2 h after apoptosis
induction. All protection assays were repeated twice and
represent the mean F standard error of three fields each
from two wells.
Op-IAP sensitization of S2 cells to viral-induced apoptosis
Virus infections were conducted at a multiplicity of
infection of 50 plaque-forming units per cell based on titers
obtained by performing plaque assays with TN-368 cells.
Virus in complete TC-100 was allowed to attach to cells for
2 h before being removed and replaced with complete TC-
100. Viable, non-apoptotic cells (based on morphology)
present at 30 h post-infection were enumerated by manually
counting the cells present in 3 random fields of view at
400 magnification in duplicate wells. The percentage of
viable cells remaining in each virus-infected sample was
then generated by dividing the number of cells present by
the number present in the mock-infected sample at the same
time point (set at 100%). For the caspase assays, cells were
harvested at 30 h post-infection and collected by centrifu-
gation at 2880  g for 5 min. The media were aspirated and
the cells were resuspended in 100 Al of caspase activity
buffer followed by 3 cycles of freeze–thaw to rupture the
cells. The cellular debris was collected by centrifugation at
2000  g for 2 min and the supernatant was transferred to a
new tube. The supernatant was incubated at 37 8C for
20 min. 30 Al was removed and used to quantify caspase
activity as described above.
Immunofluorescence assay
S2 cells were infected as described above and at 12 h
post-infection the cells were washed with phosphate-
buffered saline (PBS). All of the following washes were
also done with PBS. The cells were then incubated 15 min
with 1% bovine serum albumin in PBS (PBS–BSA). After 2
washes, the cells were fixed for 20 min in 2% paraformalde-
hyde in PBS. Following 3 washes, cells were permeabilized
for 10 min with 0.2% Triton X-100 in PBS. Cells were
washed 3 times, incubated with PBS–BSA, and washed 2
more times. Cells were then incubated for 1 h at 4 8C with
anti-IE1 monoclonal antibody (kindly provided by Linda
Guarino, Texas A and M University) diluted 1:100. Follow-
ing 3 washes, cells were incubated again for 15 min with 1%
PBS–BSA, washed 2 times, and incubated 30 min at 4 8C
with goat anti-mouse IgG labeled with R-phycoerythrin
(SouthernBiotech, Birmingham, AL) diluted 1:250. Stained
cells were washed 3 times and observed with a Nikon TE200
microscope equipped with epifluorescence.Acknowledgments
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